Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11h-dibenzo[b,e][1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes

Biochemical Pharmacology

Volumn 57, Issue 2, 1999, Pages 181-186

  Ellis, John ^a   Seidenberg, Margaret ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Allosteric site; Chimeric proteins; Epitopes; Gallamine; Muscarinic receptors; UH AH 37

Indexed keywords

6 CHLORO 5,10 DIHYDRO 5 [(1 METHYL 4 PIPERIDYL)ACETYL] 11H DIBENZO[B,E][1,4]DIAZEPIN 11 ONE; ATROPINE; CHIMERIC PROTEIN; EPITOPE; GALLAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DISSOCIATION; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; PRIORITY JOURNAL;

ALLOSTERIC REGULATION; BENZODIAZEPINONES; BINDING, COMPETITIVE; DIBENZAZEPINES; EPITOPES; LOGISTIC MODELS; MOLECULAR STRUCTURE; RECEPTORS, MUSCARINIC; RECOMBINANT FUSION PROTEINS;

EID: 0032927395     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00276-7     Document Type: Article

References (19)

1. Jones S.V., Levey A.I., Weiner D.M., Ellis J., Novotny E., Yu S.H., Dorje F., Wess J., Brann M.R. Muscarinic acetylcholine receptors. Brann M.R. Molecular Biology of G-Protein-Coupled Receptors. 1992;170-197 Birkhauser, Boston.
2. Ellis J. Allosteric binding sites on muscarinic receptors. Drug Dev Res. 40:1997;193-204.
3. Matsui H., Lazareno S., Birdsall N.J. Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol. 47:1995;88-98.
4. Tucek S., Proska J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci. 16:1995;205-212.
5. Ellis J., Seidenberg M., Brann M.R. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol. 44:1993;583-588.
6. Wess J., Gdula D., Brann M.R. Structural basis of the subtype selectivity of muscarinic antagonists A study with chimeric m2/m5 muscarinic receptors . Mol Pharmacol. 41:1992;369-374.
7. Wess J., Lambrecht G., Mutschler E., Brann M.R., Dorje F. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations. Br J Pharmacol. 102:1991;246-250.
8. Ellis J., Huyler J., Brann M.R. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol. 42:1991;1927-1932.
9. Ehlert F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol. 33:1988;187-194.
10. Max S.I., Liang J.S., Potter L.T. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol. 44:1993;1171-1175.
11. Potter L.T., Hanchett-Valentine H., Liang J.S., Max S.I., Purkerson S.L., Silberberg H.A., Strauss W.L. m1-Toxin. Life Sci. 52:1993;433-440.
12. Liang J.S., Carsi-Gabrenas J., Krajewski J.L., McCafferty J.M., Purkerson S.L., Santiago M.P., Strauss W.L., Valentine H.H., Potter L.T. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon. 34:1996;1257-1267.
13. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms Small proteins with selectivities for different subtypes of muscarinic receptors . Trends Pharmacol Sci. 15:1994;424-430.
14. Jakubik J., Bacakova L., El-Fakahany E.E., Tucek S. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J Pharmacol Exp Ther. 274:1995;1077-1083.
15. Lee N.H., El-Fakahany E.E. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. J Pharmacol Exp Ther. 256:1991;468-479.
16. Zhou W., Flanagan C., Ballesteros J.A., Konvicka K., Davidson J.S., Weinstein H., Millar R.P., Sealfon S.C. A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor. Mol Pharmacol. 45:1994;165-170.
17. Waelbroeck M. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol. 46:1994;685-692.
18. Kenakin T., Boselli C. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction Resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea . J Pharmacol Exp Ther. 250:1989;944-952.
19. Trankle C., Andresen I., Lambrecht G., Mohr K. M2 receptor binding of the selective antagonist AF-DX 384 Possible involvement of the common allosteric site . Mol Pharmacol. 53:1998;304-312.